Showing results (181-190 of 200) with videos related to
Sort By:
Pageof 20
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Carcinoma of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatinF A Greco, J B Erland, L H Morrissey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2001
Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research networkA A Meluch, F A Greco, H A Burris, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapyT M Waits, F A Greco, J P Greer, et al.Cancer Journal (Sudbury, Mass.)|July 6, 2000
Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research NetworkJ D Hainsworth, H A Burris, L H Morrissey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphomaJ P Greer, M C Kinney, R D Collins, et al.Bone Marrow Transplantation|December 24, 1997
A phase I-II study of high-dose melphalan, mitoxantrone and carboplatin with peripheral blood stem cell support in patients with advanced ovarian or breast carcinomaC H Weaver, F A Greco, J D Hainsworth, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1995
Adjusting the dose of intravenous ondansetron plus dexamethasone to the emetogenic potential of the chemotherapy regimenP J Hesketh, T Beck, M Uhlenhopp, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2014
Improved time to treatment failure with an intermittent oxaliplatin strategy: results of CONcePTH S Hochster, A Grothey, L Hart, et al.Clinical Pharmacology and Therapeutics|May 1, 1995
A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 daysD S Thompson, A Greco, A A Miller, et al.Seminars in Oncology|March 4, 2000
Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancerH A Burris, J D Hainsworth, J B Erland, et al.Pageof 20